54 related articles for article (PubMed ID: 18502645)
1. Atypical regulation of SRC-3.
Garabedian MJ; Logan SK
Trends Biochem Sci; 2008 Jul; 33(7):301-4. PubMed ID: 18502645
[TBL] [Abstract][Full Text] [Related]
2. Staying the distance: avoiding the proteasomal trap.
Downes M; Evans RM
Cancer Cell; 2008 Mar; 13(3):184-5. PubMed ID: 18328421
[TBL] [Abstract][Full Text] [Related]
3. Atypical protein kinase C regulates dual pathways for degradation of the oncogenic coactivator SRC-3/AIB1.
Yi P; Feng Q; Amazit L; Lonard DM; Tsai SY; Tsai MJ; O'Malley BW
Mol Cell; 2008 Feb; 29(4):465-76. PubMed ID: 18313384
[TBL] [Abstract][Full Text] [Related]
4. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome.
Li X; Lonard DM; Jung SY; Malovannaya A; Feng Q; Qin J; Tsai SY; Tsai MJ; O'Malley BW
Cell; 2006 Jan; 124(2):381-92. PubMed ID: 16439211
[TBL] [Abstract][Full Text] [Related]
5. REGgamma: a shortcut to destruction.
Zhou P
Cell; 2006 Jan; 124(2):256-7. PubMed ID: 16439199
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen-induced ER-alpha-SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence.
Mc Ilroy M; Fleming FJ; Buggy Y; Hill AD; Young LS
Endocr Relat Cancer; 2006 Dec; 13(4):1135-45. PubMed ID: 17158759
[TBL] [Abstract][Full Text] [Related]
7. PKA-induced resistance to tamoxifen is associated with an altered orientation of ERalpha towards co-activator SRC-1.
Zwart W; Griekspoor A; Berno V; Lakeman K; Jalink K; Mancini M; Neefjes J; Michalides R
EMBO J; 2007 Aug; 26(15):3534-44. PubMed ID: 17627277
[TBL] [Abstract][Full Text] [Related]
8. Regulation of SRC-3 intercompartmental dynamics by estrogen receptor and phosphorylation.
Amazit L; Pasini L; Szafran AT; Berno V; Wu RC; Mielke M; Jones ED; Mancini MG; Hinojos CA; O'Malley BW; Mancini MA
Mol Cell Biol; 2007 Oct; 27(19):6913-32. PubMed ID: 17646391
[TBL] [Abstract][Full Text] [Related]
9. Expression of steroid receptor coactivators in cultured cells from paired myometrial and fibroid tissues.
Hussein-Fikret S; Fuller PJ; Gargett CE
J Soc Gynecol Investig; 2005 Sep; 12(6):445-51. PubMed ID: 15979354
[TBL] [Abstract][Full Text] [Related]
10. Rapid estrogen-induced phosphorylation of the SRC-3 coactivator occurs in an extranuclear complex containing estrogen receptor.
Zheng FF; Wu RC; Smith CL; O'Malley BW
Mol Cell Biol; 2005 Sep; 25(18):8273-84. PubMed ID: 16135815
[TBL] [Abstract][Full Text] [Related]
11. Expression of nuclear receptor coregulators in ovarian stromal and epithelial tumours.
Hussein-Fikret S; Fuller PJ
Mol Cell Endocrinol; 2005 Jan; 229(1-2):149-60. PubMed ID: 15607539
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway.
Li X; Amazit L; Long W; Lonard DM; Monaco JJ; O'Malley BW
Mol Cell; 2007 Jun; 26(6):831-42. PubMed ID: 17588518
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cells.
Oh AS; Lahusen JT; Chien CD; Fereshteh MP; Zhang X; Dakshanamurthy S; Xu J; Kagan BL; Wellstein A; Riegel AT
Mol Cell Biol; 2008 Nov; 28(21):6580-93. PubMed ID: 18765637
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine phosphorylation of transcriptional coactivator WW-domain binding protein 2 regulates estrogen receptor α function in breast cancer via the Wnt pathway.
Lim SK; Orhant-Prioux M; Toy W; Tan KY; Lim YP
FASEB J; 2011 Sep; 25(9):3004-18. PubMed ID: 21642474
[TBL] [Abstract][Full Text] [Related]
15. Signaling within a coactivator complex: methylation of SRC-3/AIB1 is a molecular switch for complex disassembly.
Feng Q; Yi P; Wong J; O'Malley BW
Mol Cell Biol; 2006 Nov; 26(21):7846-57. PubMed ID: 16923966
[TBL] [Abstract][Full Text] [Related]
16. Expression of aromatase, estrogen receptors, and their coactivators in patients with endometrial cancer.
Pathirage N; Di Nezza LA; Salmonsen LA; Jobling T; Simpson ER; Clyne CD
Fertil Steril; 2006 Aug; 86(2):469-72. PubMed ID: 16730717
[TBL] [Abstract][Full Text] [Related]
17. Specific amino acid residues in the basic helix-loop-helix domain of SRC-3 are essential for its nuclear localization and proteasome-dependent turnover.
Li C; Wu RC; Amazit L; Tsai SY; Tsai MJ; O'Malley BW
Mol Cell Biol; 2007 Feb; 27(4):1296-308. PubMed ID: 17158932
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of estrogen receptor alpha, serine residue 305 enhances activity.
Tharakan R; Lepont P; Singleton D; Kumar R; Khan S
Mol Cell Endocrinol; 2008 Nov; 295(1-2):70-8. PubMed ID: 18755239
[TBL] [Abstract][Full Text] [Related]
19. SUG-1 plays proteolytic and non-proteolytic roles in the control of retinoic acid target genes via its interaction with SRC-3.
Ferry C; Gianni M; Lalevée S; Bruck N; Plassat JL; Raska I; Garattini E; Rochette-Egly C
J Biol Chem; 2009 Mar; 284(12):8127-35. PubMed ID: 19144644
[TBL] [Abstract][Full Text] [Related]
20. Effects of novel retinoic acid metabolism blocking agent (VN/14-1) on letrozole-insensitive breast cancer cells.
Belosay A; Brodie AM; Njar VC
Cancer Res; 2006 Dec; 66(23):11485-93. PubMed ID: 17145897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
